Clinical Trials

NCT05507892 | ACTIVE_NOT_RECRUITING | PHASE2
45 participants

Renal Mechanism of SGLT2 Inhibition

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-02
Start Date:
2022-10-10
Completion:
2026-12-15
Conditions
  • Type 2 Diabetes
  • Diabetic Kidney Disease
Interventions
  • DRUG
No Results Yet
NCT05257044 | COMPLETED | PHASE1
38 participants

Acute Effects of Cannabigerol

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-02
Start Date:
2022-03-24
Completion:
2023-11-28
Conditions
  • Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05146739 | ACTIVE_NOT_RECRUITING | PHASE1
8 participants

Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-02
Start Date:
2023-10-10
Completion:
2025-03-31
Conditions
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Myelodysplastic Syndrome Post Cytotoxic Therapy
  • Myeloid Leukemia Associated With Down Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Mixed Phenotype Acute Leukemia
  • Recurrent Myelodysplastic Syndrome
  • Refractory Acute Myeloid Leukemia
  • Refractory Mixed Phenotype Acute Leukemia
  • Refractory Myelodysplastic Syndrome
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page